Search clinical trials for: GLP-1 receptor agonist

Total 9886 results

Western University, Canada
Unity Health Toronto; Lawson Health Research Institute; Queen Elizabeth II Health...

Not yet recruiting

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

Obesity | Chronic Kidney Disease

Canada
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Healthy | Type 2 Diabetes Mellitus

United States
University of Copenhagen
Hvidovre University Hospital

Completed

Investigation of GLP-2 Mechanism of Action (GA-8)

Healthy

Denmark
University of Tartu

Completed

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

Type 2 Diabetes

Estonia
Diabeteszentrum Bad Lauterberg im Harz

Completed

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Type 2 Diabetes

Germany
Mayo Clinic
Merck Sharp & Dohme LLC

Completed

GLP1R Polymorphisms and Response to GLP1

Diabetes

United States
Institut de Recherches Internationales Servier

Active, not recruiting

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

Glioma

United States
Papworth Hospital NHS Foundation Trust

Completed

Human Vasodilatory Effect of GLP-1

Angina, Stable | Type2 Diabetes | Coronary Stenosis
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

Hyperglycemia | Glucose Intolerance | Hyperglucagonemia
Aarhus University Hospital Skejby
Aarhus University Hospital; University of Aarhus

Completed

Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure

Heart Failure, Congestive

Denmark
University of Copenhagen
The Danish Medical Research Council

Completed

The Interaction Between Appetite Hormones

Obesity

Denmark
CellMed AG, a subsidiary of BTG plc.

Terminated

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Intracerebral Hemorrhage (ICH)

Germany
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

Obesity

United States
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

Vagotomy, Truncal

Denmark
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Completed

Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects

Glucose Homeostasis

Switzerland
Uppsala University
Karolinska Institutet; University of Copenhagen

Completed

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose (GIP-GLP-gas)

Physiology | Gastroenterology | Endocrinology

Sweden
Papworth Hospital NHS Foundation Trust

Unknown

GLP-1 Loading During Elective Percutaneous Coronary Intervention (GOLD-PCI)

Myocardial Infarction | Angina Pectoris | Coronary Heart Disease | Reperfusion Injury

United Kingdom
Johns Hopkins University

Terminated

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery (GLP-1 CABG)

CABG

United States
Bayer

Active, not recruiting

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice (FINEGUST)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Japan, Spain, Netherlands, Denmark, United States
Danish Headache Center

Unknown

Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

Headache, Migraine

Denmark
University of Copenhagen
Copenhagen University Hospital, Hvidovre

Recruiting

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Obesity

Denmark
University of Padova
Azienda Ospedaliera di Padova

Unknown

GLP-1 REceptor Agonists and Real World EvIdeNce (GLP-1REWIN)

Type 2 Diabetes

Italy
University of Copenhagen

Completed

Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism. (INGEAR-1)

Obesity

Denmark
University Hospital, Basel, Switzerland

Completed

Oral Administration of Peptides; Absorption From Gastrointestinal Tract

Healthy

Switzerland
Shanghai 10th People's Hospital

Completed

GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

China
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Not yet recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
Sapporo Medical University
Merck Sharp & Dohme LLC

Completed

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Coronary Artery Disease

Japan
University of Pennsylvania

Completed

GLP 1 for Intraoperative Glycemic Control (GLP)

Hyperglycemia | Hypoglycemia

United States
Rigshospitalet, Denmark
Department of Cardiovascular and Renal Research, University of Southern Denmark

Completed

Acute Effects of GLP-1 on Renal Hemodynamics (GLP1RRBF)

The GLP-1-mediated Gut-kidney Axis

Denmark
Assaf-Harofeh Medical Center

Unknown

Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2 (GLP)

Diabetes Mellitus Type 2

Israel
RenJi Hospital

Completed

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

Polycystic Ovary Syndrome

China
Jeppe Skov
Novo Nordisk A/S

Completed

GLP-1: Acute Effects on Kidney Function in Healthy Men

Kidney Functional

Denmark
AstraZeneca

Not yet recruiting

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED)

Pancreatic Cancer
University of Maryland, Baltimore

Active, not recruiting

GLP-1 and Hypoglycemia

Type 2 Diabetes Mellitus

United States
Zealand University Hospital
University of Copenhagen; Glostrup University Hospital, Copenhagen

Unknown

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

Healthy

Denmark
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma

United States
University Hospital, Gentofte, Copenhagen

Completed

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

Obesity | Incretin Action

Denmark
Rigshospitalet, Denmark
Novo Nordisk A/S; University of Copenhagen

Completed

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

Hypoglycaemia

Denmark
Diabetes Care Center of Nanjing Military Command

Unknown

Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

Type 2 Diabetes

China
University Hospital, Gentofte, Copenhagen

Completed

Physiology of GIP(1-30)NH2 in Humans (GA-11)

Glucose Metabolism Disorders

Denmark
Katarina Kos
University of Exeter

Terminated

Incretin and KATP Channels

Healthy Subjects

United Kingdom
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Recruiting

The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes (GIPHYPO)

Hypoglycemia | Type1diabetes | Type 1 Diabetes

Denmark
Mikkel Christensen

Completed

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

Type 1 Diabetes Mellitus
Lesaffre International
BioFortis; Soladis

Terminated

Bioavailability Study of Folate in Healthy Subjects

Healthy

France
The University of Texas Health Science Center at...

Recruiting

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Hypoglycemia | Post Bariatricsurgery

United States
Amir Moheet
Cystic Fibrosis Foundation

Recruiting

Semaglutide in CFRD

Cystic Fibrosis | Cystic Fibrosis-related Diabetes

United States
Katarina Kos
Diabetes UK

Completed

The Microvascular Function of GLP-1 and Its Analogues

Obesity | Type 2 Diabetes

United Kingdom
University of California, San Francisco

Completed

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

Type 2 Diabetes Mellitus

United States
Elahi, Dariush, PhD
Massachusetts General Hospital; National Institute on Aging (NIA); ICON plc

Unknown

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man (LVKGR)

Insulin Resistance

United States
GeneOne Life Science, Inc.

Active, not recruiting

GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)

COVID-19 | Healthy

Puerto Rico, United States

Search clinical trials for: GLP-1 receptor agonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations